Provins
Jarrod Provins, Dana Point, CA US
Patent application number | Description | Published |
---|---|---|
20090081670 | NICKING AND EXTENSION AMPLIFICATION REACTION FOR THE EXPONENTIAL AMPLIFICATION OF NUCLEIC ACIDS - The invention is in general directed to the rapid exponential amplification of short DNA or RNA sequences at a constant temperature. | 03-26-2009 |
20130330777 | NUCLEIC ACID AMPLIFICATIONS - A method includes combining a polynucleotide and an amplification reagent mixture to form a reaction mixture, wherein the reaction mixture comprises reversibly bound divalent ions in solution, and adjusting the pH of the reaction mixture to release the reversibly bound divalent ions, thereby initiating amplification of the polynucleotide. | 12-12-2013 |
20140072978 | Nicking and Extension Amplification Reaction for the Exponential Amplification of Nucleic Acids - The invention is in general directed to the rapid exponential amplification of short DNA or RNA sequences at a constant temperature. | 03-13-2014 |
20140093883 | Nicking and Extension Amplification Reaction for the Exponential Amplification of Nucleic Acids - The invention is in general directed to the rapid exponential amplification of short DNA or RNA sequences at a constant temperature. | 04-03-2014 |
Jarrod W. Provins, Dana Point, CA US
Patent application number | Description | Published |
---|---|---|
20090017453 | NICKING AND EXTENSION AMPLIFICATION REACTION FOR THE EXPONENTIAL AMPLIFICATION OF NUCLEIC ACIDS - The invention is in general directed to the rapid exponential amplification of short DNA or RNA sequences at a constant temperature. | 01-15-2009 |
Laurent Provins, Soignies BE
Patent application number | Description | Published |
---|---|---|
20090023708 | Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses - The present invention relates to compounds of formula (I) comprising a lactam or a lactam derivative moiety, processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as pharmaceuticals. | 01-22-2009 |
20100009969 | Fused Oxazoles & Thiazoles As Histamine H3- Receptor Ligands - The present invention relates to compounds comprising fused oxazole or thiazole derivatives of formula (I), processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H | 01-14-2010 |
Laurent Provins, Brussells BE
Patent application number | Description | Published |
---|---|---|
20110098300 | Compounds Comprising A Cyclobutoxy Group - The present invention relates to compounds of formula (I) comprising a cyclobutoxy group, processes for preparing them, pharmaceutical compositions comprising said compounds and their use as pharmaceuticals, useful for the treatment and prevention of diseases or pathological conditions of the central nervous system including mild-cognitive impairments, Alzheimer's disease, learning and; memory disorders, cognitive disorders, attention deficit disorder, attention-deficit hyperactivity disorder, Parkinson's disease, schizophrenia, dementia, depression, epilepsy, seizures, convulsions, sleep/wake and arousal/vigilance disorders such as hypersomnia and narcolepsy, pain and/or obesity. | 04-28-2011 |
Laurent Provins, Brussels BE
Patent application number | Description | Published |
---|---|---|
20140148489 | 2-Oxo-1-Imidazolidinyl Imidazothiadiazole Derivatives - The present invention relates to 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals. | 05-29-2014 |
Robert Provins, Glen Burnie, MD US
Patent application number | Description | Published |
---|---|---|
20130089706 | Infrared-Reflective Coatings - A composition includes polymer and dispersed infrared-reflective clusters of titanium dioxide primary particles. The titanium dioxide primary particles are cemented together with precipitated silica and/or alumina to form clusters. The titanium dioxide primary particles have an average particle diameter in the range of from about 0.15 to about 0.35 micron, while the clusters of titanium dioxide primary particles have an average cluster diameter in the range of from about 0.38 to about 5 microns and a geometric standard deviation (GSD) in the range of from about 1.55 to about 2.5. | 04-11-2013 |
Robert Provins US
Patent application number | Description | Published |
---|---|---|
20140366775 | INFRARED-REFLECTIVE COATINGS - A composition includes polymer and dispersed infrared-reflective clusters of titanium dioxide primary particles. The titanium dioxide primary particles are cemented together with precipitated silica and/or alumina to form clusters. The titanium dioxide primary particles have an average particle diameter in the range of from about 0.15 to about 0.35 micron, while the clusters of titanium dioxide primary particles have an average cluster diameter in the range of from about 0.38 to about 5 microns and a geometric standard deviation (GSD) in the range of from about 1.55 to about 2.5. | 12-18-2014 |